CliffBio
small molecule

THYQUIDITY

LEVOTHYROXINE SODIUM

Loss of exclusivityAugust 2031latest FDA-listed patent expiry
CompanyJEROME STEVENS PHARMACEUTICALS INC

Drug detail

Brand nameTHYQUIDITY
Active ingredientLEVOTHYROXINE SODIUM
Strength100MCG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2020
Marketing statusRX

Listed patents

PatentExpiresType
9050307August 2031product

More from JEROME STEVENS PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

THYQUIDITY patent cliff — loss of exclusivity August 2031 | CliffBio